{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:20:45Z","timestamp":1788279645128,"version":"build-2803163510"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bioadv.2026.215098","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T07:00:06Z","timestamp":1785826806000},"page":"215098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Synthetic artificial platelets: Design, structure, properties"],"prefix":"10.1016","volume":"189","author":[{"given":"Anna K.","family":"Chumicheva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina A.","family":"Didenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasiia V.","family":"Igushkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioadv.2026.215098_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00678","article-title":"Platelets in inflammation: regulation of leukocyte activities and vascular repair","volume":"5","author":"Gros","year":"2015","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bioadv.2026.215098_bb0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.blre.2011.03.002","article-title":"Platelets at work in primary hemostasis","volume":"25","author":"Broos","year":"2011","journal-title":"Blood Rev."},{"issue":"4","key":"10.1016\/j.bioadv.2026.215098_bb0015","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cll.2025.07.009","article-title":"Platelet subpopulations: characteristics, function, clinical relevance, and translational potential","volume":"45","author":"Song","year":"2025","journal-title":"Clin. Lab. Med."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215098_bb0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00277-026-06758-y","article-title":"The evolving landscape of platelet therapy: Risks, innovations, and clinical judgment","volume":"105","author":"Mushtaq","year":"2026","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215098_bb0025","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tracli.2022.08.147","article-title":"Platelet transfusion in adults: an update","volume":"30","author":"Garraud","year":"2023","journal-title":"Transfus. Clin. Biol."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215098_bb0030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/09537104.2021.1961711","article-title":"Current challenges in platelet transfusion","volume":"33","author":"Smethurst","year":"2022","journal-title":"Platelets"},{"issue":"2","key":"10.1016\/j.bioadv.2026.215098_bb0035","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.transci.2009.07.002","article-title":"The platelet storage lesion","volume":"41","author":"Shrivastava","year":"2009","journal-title":"Transfus. Apher. Sci."},{"issue":"1\u20132","key":"10.1016\/j.bioadv.2026.215098_bb0040","article-title":"The platelet storage lesion, what are we working for?","volume":"38","author":"Liu","year":"2024","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.bioadv.2026.215098_bb0045","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.20816.1","article-title":"Platelets treated with pathogen reduction technology: current status and future direction","volume":"9","author":"Lu","year":"2020","journal-title":"F1000Res"},{"key":"10.1016\/j.bioadv.2026.215098_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.1073318","article-title":"Cryopreserved platelets in bleeding management in remote hospitals: a clinical feasibility study in Sweden","volume":"10","author":"Wikman","year":"2023","journal-title":"Front. Public Health"},{"issue":"14","key":"10.1016\/j.bioadv.2026.215098_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25147779","article-title":"Platelet storage-problems, improvements, and new perspectives","volume":"25","author":"Trochanowska-Pauk","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bioadv.2026.215098_bb0060","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tmrv.2020.09.010","article-title":"Human, leukocyte antigen alloimmunization and alloimmune platelet refractoriness","volume":"34","author":"Saris","year":"2020","journal-title":"Transfus. Med. Rev."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215098_bb0065","doi-asserted-by":"crossref","DOI":"10.1080\/09537104.2024.2306983","article-title":"Immunological platelet transfusion refractoriness: current insights from mechanisms to therapeutics","volume":"35","author":"Chen","year":"2024","journal-title":"Platelets"},{"issue":"7","key":"10.1016\/j.bioadv.2026.215098_bb0070","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/jth.15734","article-title":"Platelet-inspired nanomedicine in hemostasis thrombosis and thromboinflammation","volume":"20","author":"Raghunathan","year":"2022","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bioadv.2026.215098_bb0075","series-title":"Transfusion Medicine and Hemostasis","first-page":"693","article-title":"Measurement of platelet count, mean platelet volume, and reticulated platelets","author":"Gil","year":"2025"},{"key":"10.1016\/j.bioadv.2026.215098_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2025.1636893","article-title":"The role of protease-activated receptors (PARs) in the functioning of platelets and platelet-derived microparticles (PMPs)","volume":"12","author":"Jakobsche-Policht","year":"2025","journal-title":"Front. Mol. Biosci."},{"issue":"3","key":"10.1016\/j.bioadv.2026.215098_bb0085","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1365-2613.2000.00155.x","article-title":"The extracellular matrix can regulate vascular cell migration, proliferation, and survival: Relationships to vascular disease","volume":"81","author":"Raines","year":"2000","journal-title":"Int. J. Exp. Pathol."},{"issue":"5","key":"10.1016\/j.bioadv.2026.215098_bb0090","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/09537104.2018.1514109","article-title":"The platelet shape change: biophysical basis and physiological consequences","volume":"30","author":"Moskalensky","year":"2019","journal-title":"Platelets"},{"issue":"3","key":"10.1016\/j.bioadv.2026.215098_bb0095","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/MBC.0000000000001130","article-title":"The role of thrombin in haemostasis","volume":"33","author":"Al-Amer","year":"2022","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"1","key":"10.1016\/j.bioadv.2026.215098_bb0100","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40364-021-00346-0","article-title":"The role of phosphatidylserine on the membrane in immunity and blood coagulation","volume":"10","author":"Wang","year":"2022","journal-title":"Biomark. Res."},{"key":"10.1016\/j.bioadv.2026.215098_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/bmm2.70101","article-title":"Harnessing blood clot as a native scaffold for orchestrating tissue repairs and regeneration","author":"Dang","year":"2026","journal-title":"BMEMat"},{"issue":"04","key":"10.1016\/j.bioadv.2026.215098_bb0110","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1160\/TH04-12-0842","article-title":"Structure and function of the plasminogen\/plasmin system","volume":"93","author":"Castellino","year":"2005","journal-title":"Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.bioadv.2026.215098_bb0115","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.sbi.2013.10.006","article-title":"New insights into the structure and function of the plasminogen\/plasmin system","volume":"23","author":"Law","year":"2013","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215098_bb0120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41368-025-00373-9","article-title":"Platelet methyltransferase-like protein 4-mediated mitochondrial DNA metabolic disorder exacerbates oral mucosal immunopathology in hypoxia","volume":"17","author":"Zhu","year":"2025","journal-title":"Int. J. Oral Sci."},{"issue":"9","key":"10.1016\/j.bioadv.2026.215098_bb0125","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/ijc.29847","article-title":"Platelets in cancer metastasis: to help the \u201cvillain\u201d to do evil","volume":"138","author":"Li","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.bioadv.2026.215098_bb0130","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1021\/bm015554o","article-title":"Fibrinogen-conjugated albumin polymers and their interaction with platelets under flow conditions","volume":"2","author":"Takeoka","year":"2001","journal-title":"Biomacromolecules"},{"issue":"1","key":"10.1016\/j.bioadv.2026.215098_bb0135","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/4795","article-title":"Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits","volume":"5","author":"Levi","year":"1999","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.bioadv.2026.215098_bb0140","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1021\/bm3013023","article-title":"Intravenous hemostatic nanoparticles increase survival following blunt trauma injury","volume":"13","author":"Shoffstall","year":"2012","journal-title":"Biomacromolecules"},{"issue":"1","key":"10.1016\/j.bioadv.2026.215098_bb0145","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12951-025-03180-w","article-title":"Injectable platelet-mimicking silk protein-peptide conjugate microspheres for hemostasis modulation and targeted treatment of internal bleeding","volume":"23","author":"Shuai","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"11","key":"10.1016\/j.bioadv.2026.215098_bb0150","doi-asserted-by":"crossref","first-page":"11ra22","DOI":"10.1126\/scitranslmed.3000397","article-title":"Intravenous hemostat: nanotechnology to halt bleeding","volume":"1","author":"Bertram","year":"2009","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.bioadv.2026.215098_bb0155","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/jth.13579","article-title":"In vitro characterization of SynthoPlateTM (Synthetic Platelet) technology and its in vivo evaluation in severely thrombocytopenic mice","volume":"15","author":"Shukla","year":"2017","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.bioadv.2026.215098_bb0160","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1021\/bm300192t","article-title":"Peptide-decorated liposomes promote arrest and aggregation of activated platelets under flow on vascular injury relevant protein surfaces in vitro","volume":"13","author":"Ravikumar","year":"2012","journal-title":"Biomacromolecules"},{"issue":"6","key":"10.1016\/j.bioadv.2026.215098_bb0165","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1021\/bc300086d","article-title":"Mimicking adhesive functionalities of blood platelets using ligand-decorated liposomes","volume":"23","author":"Ravikumar","year":"2012","journal-title":"Bioconjug. Chem."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215098_bb0170","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-21384-z","article-title":"Intravenous synthetic platelet (SynthoPlate) nanoconstructs reduce bleeding and improve \u201cgolden hour\u201d survival in a porcine model of traumatic arterial hemorrhage","volume":"8","author":"Hickman","year":"2018","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bioadv.2026.215098_bb0175","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/TA.0000000000001893","article-title":"Intravenous administration of synthetic platelets (SynthoPlate) in a mouse liver injury model of uncontrolled hemorrhage improves hemostasis","volume":"84","author":"Dyer","year":"2018","journal-title":"J. Trauma Acute Care Surg."},{"issue":"9","key":"10.1016\/j.bioadv.2026.215098_bb0180","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1039\/C3NR06400J","article-title":"A factor VIII-derived peptide enables von Willebrand factor (VWF)-binding of artificial platelet nanoconstructs without interfering with VWF-adhesion of natural platelets","volume":"6","author":"Haji-Valizadeh","year":"2014","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.bioadv.2026.215098_bb0185","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/TA.0000000000003938","article-title":"Platelet-inspired synthetic nanoparticles improve hemostasis and hemodynamics in a rabbit model of abdominal hemorrhage","volume":"96","author":"Srinivasan A.","year":"2024","journal-title":"J. Trauma Acute Care Surg."},{"key":"10.1016\/j.bioadv.2026.215098_bb0190","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood.V52.2.453.453","article-title":"Fibrinogen and ADP-induced aggregation","volume":"52","author":"Mustard","year":"1978","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.bioadv.2026.215098_bb0195","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1537-2995.2007.01265.x","article-title":"Prolonged hemostatic ability of polyethylene glycol\u2013modified polymerized albumin particles carrying fibrinogen \u03b3-chain dodecapeptide","volume":"47","author":"Okamura","year":"2007","journal-title":"Transfusion"},{"issue":"28","key":"10.1016\/j.bioadv.2026.215098_bb0200","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1002\/adma.201200607","article-title":"Platelet mimetic particles for targeting thrombi in flowing blood","volume":"24","author":"Doshi","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioadv.2026.215098_bb0205","doi-asserted-by":"crossref","first-page":"11243","DOI":"10.1021\/nn503732m","article-title":"Platelet-like nanoparticles: mimicking shape, flexibility and surface biology of platelets to target vascular injuries","volume":"8","author":"Anselmo","year":"2014","journal-title":"ACS Nano"},{"issue":"31","key":"10.1016\/j.bioadv.2026.215098_bb0210","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba0588","article-title":"A polymer-based systemic hemostatic agent","volume":"6","author":"Gao","year":"2020","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.bioadv.2026.215098_bb0215","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ijpharm.2011.11.043","article-title":"Biodegradable nanoparticles mimicking platelet binding as a targeted and controlled drug delivery system","volume":"423","author":"Kona","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"742","key":"10.1016\/j.bioadv.2026.215098_bb0220","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adi4490","article-title":"Ultrasoft platelet-like particles stop bleeding in rodent and porcine models of trauma","volume":"16","author":"Nellenbach","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"12","key":"10.1016\/j.bioadv.2026.215098_bb0225","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/nmat4066","article-title":"Ultrasoft microgels displaying emergent platelet-like behaviours","volume":"13","author":"Brown","year":"2014","journal-title":"Nat. Mater."},{"issue":"4","key":"10.1016\/j.bioadv.2026.215098_bb0230","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/jbm.a.37625","article-title":"Wound-triggered shape change microgels for the development of enhanced biomimetic function platelet-like particles","volume":"112","author":"Chee","year":"2024","journal-title":"J Biomed Mater Res. Part A"},{"issue":"629","key":"10.1016\/j.bioadv.2026.215098_bb0235","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb8975","article-title":"Platelet-mimicking procoagulant nanoparticles augment hemostasis in animal models of bleeding","volume":"14","author":"Sekhon","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.bioadv.2026.215098_bb0240","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0049-3848(85)90255-5","article-title":"Comparison of the abilities of synthetic and platelet-derived membranes to enhance thrombin formation","volume":"39","author":"Jones","year":"1985","journal-title":"Thromb. Res."},{"issue":"22","key":"10.1016\/j.bioadv.2026.215098_bb0245","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1002\/smll.201401530","article-title":"Platelet-inspired multiscaled cytophilic interfaces with high specificity and efficiency toward point-of-care cancer diagnosis","volume":"10","author":"Liu","year":"2014","journal-title":"Small"},{"issue":"44","key":"10.1016\/j.bioadv.2026.215098_bb0250","doi-asserted-by":"crossref","first-page":"7043","DOI":"10.1002\/adma.201503323","article-title":"Anticancer platelet-mimicking nanovehicles","volume":"27","author":"Hu","year":"2015","journal-title":"Adv. Mater."},{"issue":"2","key":"10.1016\/j.bioadv.2026.215098_bb0255","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1039\/C8BM01201F","article-title":"Platelet-like particles dynamically stiffen fibrin matrices and improve wound healing outcomes","volume":"7","author":"Nandi","year":"2019","journal-title":"Biomater. Sci."},{"issue":"10","key":"10.1016\/j.bioadv.2026.215098_bb0260","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.2217\/nnm.13.113","article-title":"A platelet-inspired paradigm for nanomedicine targeted to multiple diseases","volume":"8","author":"Modery-Pawlowski","year":"2013","journal-title":"Nanomedicine (Lond.)"},{"issue":"1","key":"10.1016\/j.bioadv.2026.215098_bb0265","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/09537104.2021.1967916","article-title":"Bioinspired artificial platelets: past, present and future","volume":"33","author":"Luc","year":"2022","journal-title":"Platelets"},{"issue":"2","key":"10.1016\/j.bioadv.2026.215098_bb0270","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1172\/JCI115619","article-title":"Thromboerythrocytes. In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusions","volume":"89","author":"Coller","year":"1992","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215098_bb0275","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1182\/blood.V61.1.186.186","article-title":"Passive participation of fixed platelets in aggregation facilitated by covalently bound fibrinogen","volume":"61","author":"Agam","year":"1983","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bioadv.2026.215098_bb0280","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ajh.26403","article-title":"Freeze-dried platelets are a promising alternative in bleeding thrombocytopenic patients with hematological malignancies","volume":"97","author":"Ohanian","year":"2022","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bioadv.2026.215098_bb0285","doi-asserted-by":"crossref","first-page":"100S","DOI":"10.1111\/trf.12043","article-title":"Thrombosomes: a platelet-derived hemostatic agent for control of noncompressible hemorrhage","volume":"53","author":"Fitzpatrick G.","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.bioadv.2026.215098_bb0290","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1160\/TH12-02-0059","article-title":"Lyophilised reconstituted human platelets increase thrombus formation in a clinical ex vivo model of deep arterial injury","volume":"108","author":"Joshi","year":"2012","journal-title":"Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.bioadv.2026.215098_bb0295","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1046\/j.1537-2995.1996.36696269513.x","article-title":"Infusible platelet membrane microvesicles: a potential transfusion substitute for platelets","volume":"36","author":"Chao","year":"1996","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.bioadv.2026.215098_bb0300","first-page":"337","article-title":"Infusible platelet membrane as a platelet substitute for transfusion: an overview","volume":"11","author":"Nasiri","year":"2013","journal-title":"Blood Transfus."},{"key":"10.1016\/j.bioadv.2026.215098_bb0305","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1309\/CCDV-3BEP-XXKP-BKDM","article-title":"Infusible platelet membranes retain partial functionality of the platelet GPIb\/IX\/V receptor complex","volume":"115","author":"Graham","year":"2001","journal-title":"Am. J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215098_bb0310","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s42003-025-08017-8","article-title":"Programming megakaryocytes to produce engineered platelets for delivering non-native proteins","volume":"8","author":"Islam","year":"2025","journal-title":"Commun. Biol."},{"issue":"6","key":"10.1016\/j.bioadv.2026.215098_bb0315","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1021\/bc050178g","article-title":"Hemostatic effects of phospholipid vesicles carrying fibrinogen gamma chain dodecapeptide in vitro and in vivo","volume":"16","author":"Okamura","year":"2005","journal-title":"Bioconjug. Chem."},{"issue":"2","key":"10.1016\/j.bioadv.2026.215098_bb0320","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.nano.2009.07.004","article-title":"Visualization of liposomes carrying fibrinogen \u03b3-chain dodecapeptide accumulated to sites of vascular injury using computed tomography","volume":"6","author":"Okamura","year":"2010","journal-title":"Nanomedicine"},{"issue":"9","key":"10.1016\/j.bioadv.2026.215098_bb0325","doi-asserted-by":"crossref","first-page":"10444","DOI":"10.3390\/cimb46090621","article-title":"Hyaluronic acid in nanopharmaceuticals: an overview","volume":"46","author":"Matalqah","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"issue":"8","key":"10.1016\/j.bioadv.2026.215098_bb0330","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1021\/acs.biomac.9b00564","article-title":"Hyaluronic acid derivatives for translational medicines","volume":"20","author":"Kim","year":"2019","journal-title":"Biomacromolecules"},{"issue":"5","key":"10.1016\/j.bioadv.2026.215098_bb0335","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1055\/s-0039-1692395","article-title":"Vascular nanomedicine: current status, opportunities, and challenges","volume":"46","author":"Sun","year":"2020","journal-title":"Semin. Thromb. Hemost."},{"issue":"7","key":"10.1016\/j.bioadv.2026.215098_bb0340","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1537-2995.2005.00173.x","article-title":"Hemostatic effects of fibrinogen gamma-chain dodecapeptide-conjugated polymerized albumin particles in vitro and in vivo","volume":"45","author":"Okamura","year":"2005","journal-title":"Transfusion"},{"issue":"11","key":"10.1016\/j.bioadv.2026.215098_bb0345","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nm1102-1227","article-title":"Platelets in atherothrombosis","volume":"8","author":"Ruggeri","year":"2002","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.bioadv.2026.215098_bb0350","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.nano.2011.04.001","article-title":"Nanomedicine approaches in vascular disease: a review","volume":"7","author":"Gupta","year":"2011","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.bioadv.2026.215098_bb0355","article-title":"Dexamethasone-loaded platelet-inspired nanoparticles improve intracortical microelectrode recording performance","volume":"16","author":"Li","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioadv.2026.215098_bb0360","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biomaterials.2015.10.046","article-title":"Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles","volume":"76","author":"Li","year":"2016","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.bioadv.2026.215098_bb0365","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jconrel.2011.10.006","article-title":"Modeling of diffusion controlled drug delivery","volume":"161","author":"Siepmann","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2026.215098_bb0370","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.biomaterials.2017.03.012","article-title":"Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis","volume":"128","author":"Pawlowski","year":"2017","journal-title":"Biomaterials"},{"issue":"15","key":"10.1016\/j.bioadv.2026.215098_bb0375","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.addr.2006.09.020","article-title":"Thermo- and pH-responsive polymers in drug delivery","volume":"58","author":"Schmaljohann","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.bioadv.2026.215098_bb0380","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1021\/bm801127d","article-title":"Stimuli-responsive polymersomes for programmed drug delivery","volume":"10","author":"Meng","year":"2009","journal-title":"Biomacromolecules"},{"issue":"6095","key":"10.1016\/j.bioadv.2026.215098_bb0385","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1126\/science.1217815","article-title":"Shear-activated nanotherapeutics for drug targeting to obstructed blood vessels","volume":"337","author":"Korin","year":"2012","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.bioadv.2026.215098_bb0390","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nnano.2012.84","article-title":"Shear-stress sensitive lenticular vesicles for targeted drug delivery","volume":"7","author":"Holme","year":"2012","journal-title":"Nat. Nanotechnol."},{"issue":"1\u20132","key":"10.1016\/j.bioadv.2026.215098_bb0395","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijpharm.2015.06.005","article-title":"Enzymatic action of phospholipase A\u2082 on liposomal drug delivery systems","volume":"491","author":"Hansen","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.bioadv.2026.215098_bb0400","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nnano.2007.223","article-title":"Immunological properties of engineered nanomaterials","volume":"2","author":"Dobrovolskaia","year":"2007","journal-title":"Nat. Nanotechnol."},{"issue":"9","key":"10.1016\/j.bioadv.2026.215098_bb0405","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16091172","article-title":"Exploring protein-based carriers in drug delivery: a review","volume":"16","author":"Ferraro","year":"2024","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.bioadv.2026.215098_bb0410","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers"},{"issue":"9","key":"10.1016\/j.bioadv.2026.215098_bb0415","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12090903","article-title":"PLGA based drug carrier and pharmaceutical applications: the most recent advances","volume":"12","author":"Loureiro","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioadv.2026.215098_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121265","article-title":"Effect of polymer source variation on the properties and performance of risperidone microspheres","volume":"610","author":"Wan","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.bioadv.2026.215098_bb0425","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/0192623318810199","article-title":"Local toxicity of topically administrated thermoresponsive systems: in vitro studies with in vivo correlation","volume":"47","author":"Yogev","year":"2019","journal-title":"Toxicol. Pathol."},{"issue":"4","key":"10.1016\/j.bioadv.2026.215098_bb0430","doi-asserted-by":"crossref","DOI":"10.3390\/gels3040036","article-title":"Poly(N-isopropylacrylamide) and copolymers: a review on recent progresses in biomedical applications","volume":"3","author":"Lanzalaco","year":"2017","journal-title":"Gels"},{"key":"10.1016\/j.bioadv.2026.215098_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2023.102983","article-title":"Synthetic and biopolymeric microgels: review of similarities and difference in behaviour in bulk phases and at interfaces","volume":"320","author":"Akgonullu","year":"2023","journal-title":"Adv. Colloid Interf. Sci."},{"key":"10.1016\/j.bioadv.2026.215098_bb0440","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.910290","article-title":"Advances in hyaluronic acid for biomedical applications","volume":"10","author":"Yasin","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"12","key":"10.1016\/j.bioadv.2026.215098_bb0445","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/nnano.2012.207","article-title":"Biomolecular coronas provide the biological identity of nanosized materials","volume":"7","author":"Monopoli","year":"2012","journal-title":"Nat. Nanotechnol."},{"issue":"4","key":"10.1016\/j.bioadv.2026.215098_bb0450","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1788","article-title":"Influence of surface chemistry and morphology of nanoparticles on protein corona formation","volume":"14","author":"Bilardo","year":"2022","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"5","key":"10.1016\/j.bioadv.2026.215098_bb0455","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/wnan.1339","article-title":"Anti-PEG immunity: emergence, characteristics, and unaddressed questions","volume":"7","author":"Yang","year":"2015","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.bioadv.2026.215098_bb0460","article-title":"Overcoming PEG antigenicity: statistical PEG isomers reduce antibody binding","author":"Deuker","year":"2025","journal-title":"Adv. Sci."},{"issue":"2","key":"10.1016\/j.bioadv.2026.215098_bb0465","doi-asserted-by":"crossref","DOI":"10.1002\/pro.2203","article-title":"Mutations for decreasing the immunogenicity and maintaining the function of core streptavidin","volume":"22","author":"Yumura","year":"2013","journal-title":"Protein Sci."},{"key":"10.1016\/j.bioadv.2026.215098_bb0470","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jconrel.2016.11.016","article-title":"The principles and applications of avidin-based nanoparticles in drug delivery and diagnosis","volume":"245","author":"Jain","year":"2017","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.bioadv.2026.215098_bb0475","doi-asserted-by":"crossref","DOI":"10.3390\/biom9080330","article-title":"Cytotoxicity of dendrimers","volume":"9","author":"Janaszewska","year":"2019","journal-title":"Biomolecules"},{"issue":"23","key":"10.1016\/j.bioadv.2026.215098_bb0480","doi-asserted-by":"crossref","first-page":"24899","DOI":"10.1021\/acsomega.4c01775","article-title":"Data-driven approaches to predict dendrimer cytotoxicity","volume":"9","author":"Maity","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioadv.2026.215098_bb0485","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.apmt.2018.05.002","article-title":"PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy","volume":"12","author":"Abedi-Gaballu","year":"2018","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.bioadv.2026.215098_bb0490","series-title":"Synthetic platelets. U.S. Patent No. 12,161,698 B2. Filed September 13, 2022. Issued December 10, 2024","author":"Gupta","year":"2024"},{"key":"10.1016\/j.bioadv.2026.215098_bb0495","series-title":"U.S. Patent No. 9,988,603. 5 Jun","article-title":"Large scale generation of functional megakaryocytes and platelets from human embryonic stem cells under stromal-free conditions","author":"Li","year":"2018"},{"key":"10.1016\/j.bioadv.2026.215098_bb0500","series-title":"U.S. Patent No. 20230149468A1. 15 Nov","article-title":"Platelet derived extracellular vesicles","author":"Antebi","year":"2022"},{"key":"10.1016\/j.bioadv.2026.215098_bb0505","series-title":"U.S. Patent No. US10363226B2. 30 Jul","article-title":"Platelet membrane-coated drug delivery system","author":"Gu","year":"2019"},{"key":"10.1016\/j.bioadv.2026.215098_bb0510","doi-asserted-by":"crossref","first-page":"21495","DOI":"10.1073\/pnas.0907127106","article-title":"Red blood cell-mimicking synthetic biomaterial particles","volume":"106","author":"Doshi","year":"2009","journal-title":"PNAS"}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950826003961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950826003961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:45:44Z","timestamp":1788277544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950826003961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":102,"alternative-id":["S2772950826003961"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2026.215098","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthetic artificial platelets: Design, structure, properties","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2026.215098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"215098"}}